MINNEAPOLIS, March 29, 2011 /PRNewswire/ -- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR), producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has completed the installation of its patented Streamway System in a large Minnesota Hospital. The hospital has now completed several procedures utilizing the Streamway System and the clinical benefits, user friendliness and efficiency aspects of the System have already been acknowledged.
The Streamway System received FDA clearance in April of 2009 and has since been run in over 100 live operations as part of the Company’s product launch phase. As the system has been increasingly tested and used by various healthcare facilities, it has proven to offer a more effective and economical means for safely disposing potentially infectious fluids in operating rooms.
“Due to the rapidly increasing market need for enhanced safety and compliance to Occupational Safety and Health Administration (OSHA) standards in the operating room, more and more hospitals are now leaning towards our innovative solutions to efficiently update their facilities,” said Kevin Davidson, President of BioDrain Medical. He continued, “We are extremely excited about the installation in this Minnesota hospital and look forward to additional opportunities that may develop from this and other new relationships.”
About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid management system that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and the related germs, viruses and diseases that are potentially found in the surgical environment. Today’s manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain’s Streamway system fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).
BioDrain’s Streamway System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected, canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain’s Streamway system, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. Learn more about BioDrain Medical, Inc. by visiting www.biodrainmedical.com.
For additional requests, please visit:
http://www.biodrainmedical.com/contact.php
Forward-looking Statements:
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company’s financial position. See the Company’s most recent Quarterly Report on Form 10Q and related 8-K filings.
SOURCE BioDrain Medical, Inc.
